Targeting myocardial remodelling to develop novel therapies for heart failure-Reference-Cited by-同舟云学术

Targeting myocardial remodelling to develop novel therapies for heart failure

Published:2014-03-17 Issue:5 Volume:16 Page:494-508
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Tarone Guido¹,Balligand Jean-Luc²,Bauersachs Johann³,Clerk Angela⁴,De Windt Leon⁵,Heymans Stephane⁶,Hilfiker-Kleiner Denise⁷,Hirsch Emilio¹,Iaccarino Guido⁸⁹,Knöll Ralph¹⁰,Leite-Moreira Adelino F.¹¹,Lourenço André P.¹¹,Mayr Manuel¹²,Thum Thomas¹⁰¹³,Tocchetti Carlo G.¹⁴

Affiliation:

1. Dipartimento di Biotecnologie Molecolari e Scienze per la Salute; Università di Torino; Torino Italy

2. Institut de Recherche Expérimentale et Clinique (IREC), Pole de Pharmacologie et Thérapeutique (UCL-FATH) and Department of Medicine, Cliniques Saint-Luc; Université catholique de Louvain; Bruxelles Belgium

3. Department of Cardiology and Angiology; Medizinische Hochschule-Hannover; Hannover Germany

4. School of Biological Sciences; University of Reading; Reading UK

5. Department of Cardiology, CARIM School for Cardiovascular Diseases; Maastricht University; Maastricht The Netherlands

6. Center for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM); Maastricht University; The Netherlands

7. Molecular Cardiology, Department of Cardiology and Angiology; Medizinische Hochschule-Hannover; Hannover Germany

8. Facoltà di Medicina; Università di Salerno; Salerno Italy

9. IRCCS ‘Multimedica’; Milano Italy

10. National Heart & Lung Institute; Imperial College London; London UK

11. Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine; University of Porto; Porto Portugal

12. King's British Heart Foundation Centre; King's College London; London UK

13. Institute of Molecular and Translational Therapeutic Strategies; Hannover Medical School; Hannover Germany

14. Clinica Montevergine; Mercogliano (AV) Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ejhf.62/fullpdf

Reference124 articles.

1. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC;McMurray;Eur J Heart Fail,2012

2. Targeting myocardial substrate metabolism in heart failure: potential for new therapies;Ardehali;Eur J Heart Fail,2012

3. Adrenergic receptors and metabolism: role in development of cardiovascular disease;Ciccarelli;Front Physiol,2013

4. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia;Ciccarelli;Circulation,2011

5. Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors;Thal;Mol Pharmacol,2011

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of the nitric oxide/cGMP pathway in cardiac contraction and relaxation: Potential role in heart failure treatment;Pharmacological Research;2023-10

2. Urea Transporter B Gene Knockout Enhances Cardiac Hypertrophy Induced by Pressure Overload via NO and ROS Imbalance;J BIOL REG HOMEOS AG;2023

3. Phosphatidylethanolamine aggravates Angiotensin II-induced atrial fibrosis by triggering ferroptosis in mice;Frontiers in Pharmacology;2023-05-23

4. Cardiac Reverse Remodeling in Ischemic Heart Disease with Novel Therapies for Heart Failure with Reduced Ejection Fraction;Life;2023-04-13

5. MicroRNA-19 upregulation attenuates cardiac fibrosis via targeting connective tissue growth factor;The American Journal of the Medical Sciences;2023-04